A study in humans demonstrated that the mir-6781-5p was downregulated in whole blood of patients with recurrent myocardial infarction after percutaneous coronary intervention compared to stable coronary artery disease patients, with this differential expression achieving significance after false-discovery rate correction in a replication cohort [Onuoha et al. DOI:10.1111/cts.13307].